Yaning Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yaning Yang has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Min Yuan
Department of Health Data Science, Anhui Medical University, Hefei, China
3 shared publications - Jinfeng Xu
City University of Hong Kong Department of Biostatistics Hong Kong, 999077
2 shared publications - Xu Steven Xu
Clinical Pharmacology and Quantitative Science, Genmab Inc., Princeton, USA
2 shared publications - Bin Xie
Central South University 5 Chang Sha, Hunan
1 shared publication - Chenchen Nie
Hunan Cancer Hospital 3 changsha
1 shared publication - Chengqing Li
School of Computer Science, Xiangtan University, Xiangtan, China
1 shared publication
Latest Publications
- 19 November 2026
- Published by American Association for Cancer Research (AACR) in Cancer Research
Pretreatment Histopathology-Based Tumor Microenvironment Modeling Predicts Treatment-Specific Objective Responses in Non-small Cell Lung Cancer
Accurate prediction of treatment response remains challenging in cancer. To facilitate response prediction in non-small cell lung cancer (NSCLC), we developed PRISM, an interpretable multiscale graph-learning framework for estimating treatment-specific objective response from pretreatment H&E whole-slide images. PRISM integrated multiresolution tissue representations with a cell-level tumor microenvironment (TME) hypergraph, thereby treating higher-order microenvironmental organization as a learnable component of treatment-response prediction. Samples from 7,082 patients from four Chinese centers were screened. PRISM was evaluated across treatment specific cohorts receiving targeted therapy (T), EGFR-targeted therapy (T_EGFR), immune checkpoint inhibitor–based therapy (ICI), chemoimmunotherapy (CI), and chemotherapy (C) using patient-level internal cross-validation, independent multicenter external validation, and prospective silent validation. PRISM predicted early objective responses across prespecified systemic therapies in NSCLC. In comparison to 18 established multiple-instance learning and computational pathology baseline models, PRISM remained competitive, with numerical advantages in selected tasks. Multiscale attribution and exploratory H&E-derived TME analyses provided spatial context for model predictions. Overall, PRISM offers a morphology-based framework for estimating early response to prespecified systemic therapies and warrants further prospective multicenter evaluation.
- 19 November 2026
- Published by American Association for Cancer Research (AACR) in Cancer Research
Pretreatment Histopathology-Based Tumor Microenvironment Modeling Predicts Treatment-Specific Objective Responses in Non-small Cell Lung Cancer
Accurate prediction of treatment response remains challenging in cancer. To facilitate response prediction in non-small cell lung cancer (NSCLC), we developed PRISM, an interpretable multiscale graph-learning framework for estimating treatment-specific objective response from pretreatment H&E whole-slide images. PRISM integrated multiresolution tissue representations with a cell-level tumor microenvironment (TME) hypergraph, thereby treating higher-order microenvironmental organization as a learnable component of treatment-response prediction. Samples from 7,082 patients from four Chinese centers were screened. PRISM was evaluated across treatment specific cohorts receiving targeted therapy (T), EGFR-targeted therapy (T_EGFR), immune checkpoint inhibitor–based therapy (ICI), chemoimmunotherapy (CI), and chemotherapy (C) using patient-level internal cross-validation, independent multicenter external validation, and prospective silent validation. PRISM predicted early objective responses across prespecified systemic therapies in NSCLC. In comparison to 18 established multiple-instance learning and computational pathology baseline models, PRISM remained competitive, with numerical advantages in selected tasks. Multiscale attribution and exploratory H&E-derived TME analyses provided spatial context for model predictions. Overall, PRISM offers a morphology-based framework for estimating early response to prespecified systemic therapies and warrants further prospective multicenter evaluation.
- Open Access
- 8 August 2026
- Published by Association for Computing Machinery (ACM)
- p. 12231-12242
DeepTaxon: An Interpretable Retrieval-Augmented Multimodal Framework for Unified Species Identification and Discovery
- 8 August 2026
- Published by Association for Computing Machinery (ACM)
- p. 12231-12242
Open AccessDeepTaxon: An Interpretable Retrieval-Augmented Multimodal Framework for Unified Species Identification and Discovery
- 20 June 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Parallel and Distributed Systems
- Vol. 36 (8) , 1797-1809
Parallel Acceleration of Genome Variation Detection on Multi-Zone Heterogeneous System
Genomic variation is critical for understanding the genetic basis of disease. Pindel, a widely used structural variant caller, leverages short-read sequencing data to detect variation at single-base resolution; however, its hotspot module imposes substantial computational demands, limiting efficiency in large-scale whole-genome analyses. Heterogeneous architectures offer a promising solution, yet disparities in hardware design and programming models preclude direct porting of the original algorithm. To address this, we introduce MTPindel, a novel heterogeneous parallel optimization framework tailored to the MT-3000 processor. Focusing on Pindel's most compute-intensive modules, we design multi-core and task-level parallel algorithms that exploit the MT-3000's accelerator domains to balance and accelerate workload distribution. On 128 MT-3000–equipped nodes of the Tianhe next-generation supercomputer, MTPindel achieves an impressive 122.549 times of speedup and 95.74% parallel efficiency, with only a 0.74% error margin relative to the original implementation. This work represents a pioneering effort in heterogeneous parallelization for variant detection, paving the way for rapid, large-scale genomic analyses in research and clinical settings.
- 20 June 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Parallel and Distributed Systems
- Vol. 36 (8) , 1797-1809
Parallel Acceleration of Genome Variation Detection on Multi-Zone Heterogeneous System
Genomic variation is critical for understanding the genetic basis of disease. Pindel, a widely used structural variant caller, leverages short-read sequencing data to detect variation at single-base resolution; however, its hotspot module imposes substantial computational demands, limiting efficiency in large-scale whole-genome analyses. Heterogeneous architectures offer a promising solution, yet disparities in hardware design and programming models preclude direct porting of the original algorithm. To address this, we introduce MTPindel, a novel heterogeneous parallel optimization framework tailored to the MT-3000 processor. Focusing on Pindel's most compute-intensive modules, we design multi-core and task-level parallel algorithms that exploit the MT-3000's accelerator domains to balance and accelerate workload distribution. On 128 MT-3000–equipped nodes of the Tianhe next-generation supercomputer, MTPindel achieves an impressive 122.549 times of speedup and 95.74% parallel efficiency, with only a 0.74% error margin relative to the original implementation. This work represents a pioneering effort in heterogeneous parallelization for variant detection, paving the way for rapid, large-scale genomic analyses in research and clinical settings.
- 23 May 2022
- Published by Elsevier in Computational Biology and Chemistry
- Vol. 99, 107697
Bias correction for multiple covariate analysis using empirical bayesian estimation in mixed-effects models for longitudinal data
- 23 May 2022
- Published by Elsevier in Computational Biology and Chemistry
- Vol. 99, 107697
Bias correction for multiple covariate analysis using empirical bayesian estimation in mixed-effects models for longitudinal data
- 1 October 2020
- Published by Elsevier in Computational Biology and Chemistry
- Vol. 88, 107320
Adaptive weighted sum tests via LASSO method in multi-locus family-based association analysis
- 1 October 2020
- Published by Elsevier in Computational Biology and Chemistry
- Vol. 88, 107320
Adaptive weighted sum tests via LASSO method in multi-locus family-based association analysis
- 9 November 2018
- Published by SAGE Publications in Statistical Methods in Medical Research
- Vol. 28 (12) , 3568-3578
A quick and accurate method for the estimation of covariate effects based on empirical Bayes estimates in mixed-effects modeling: Correction of bias due to shrinkage
Nonlinear mixed-effects modeling is a popular approach to describe the temporal trajectory of repeated measurements of clinical endpoints collected over time in clinical trials, to distinguish the within-subject and the between-subject variabilities, and to investigate clinically important risk factors (covariates) that may partly explain the between-subject variability. Due to the complex computing algorithms involved in nonlinear mixed-effects modeling, estimation of covariate effects is often time-consuming and error-prone owing to local convergence. We develop a fast and accurate estimation method based on empirical Bayes estimates from the base mixed-effects model without covariates, and simple regressions outside of the nonlinear mixed-effect modeling framework. Application of the method is illustrated using a pharmacokinetic dataset from an anticoagulation drug for the prevention of major cardiovascular events in patients with acute coronary syndrome. Both the application and extensive simulations demonstrated that the performance of this high-throughput method is comparable to the commonly used maximum likelihood estimation in nonlinear mixed-effects modeling.
- 9 November 2018
- Published by SAGE Publications in Statistical Methods in Medical Research
- Vol. 28 (12) , 3568-3578
A quick and accurate method for the estimation of covariate effects based on empirical Bayes estimates in mixed-effects modeling: Correction of bias due to shrinkage
Nonlinear mixed-effects modeling is a popular approach to describe the temporal trajectory of repeated measurements of clinical endpoints collected over time in clinical trials, to distinguish the within-subject and the between-subject variabilities, and to investigate clinically important risk factors (covariates) that may partly explain the between-subject variability. Due to the complex computing algorithms involved in nonlinear mixed-effects modeling, estimation of covariate effects is often time-consuming and error-prone owing to local convergence. We develop a fast and accurate estimation method based on empirical Bayes estimates from the base mixed-effects model without covariates, and simple regressions outside of the nonlinear mixed-effect modeling framework. Application of the method is illustrated using a pharmacokinetic dataset from an anticoagulation drug for the prevention of major cardiovascular events in patients with acute coronary syndrome. Both the application and extensive simulations demonstrated that the performance of this high-throughput method is comparable to the commonly used maximum likelihood estimation in nonlinear mixed-effects modeling.
- Open Access
- 19 August 2008
- Published by Wiley in Statistics in Medicine
- Vol. 27 (28) , 5801-5815
Testing linkage disequilibrium from pooled DNA: A contingency table perspective
Pooling DNA samples of multiple individuals has been advocated as a method to reduce genotyping costs. Under such a scheme, only the allele counts at each locus, not the haplotype information, are observed. We develop a systematic way for handling such data by formulating the problem in terms of contingency tables, where pooled allele counts are expressed as the margins and the haplotype counts correspond to the unobserved cell counts. We show that the cell frequencies can be uniquely determined from the marginal frequencies under the usual Hardy–Weinberg equilibrium (HWE) assumption and that the maximum likelihood estimates of haplotype frequencies are consistent and asymptotically normal as the number of pools increases. The limiting covariance matrix is shown to be closely related to the extended hypergeometric distribution. Our results are used to derive Wald‐type tests for linkage disequilibrium (LD) coefficient using pooled data. It is discovered that pooling is not efficient in testing weak LD despite its efficiency in estimating haplotype frequencies. We also show by simulations that the proposed LD tests are robust to slight deviation from HWE and to minor genotype error. Applications to two real angiotensinogen gene data sets are also provided. Copyright © 2008 John Wiley & Sons, Ltd.
- 19 August 2008
- Published by Wiley in Statistics in Medicine
- Vol. 27 (28) , 5801-5815
Open AccessTesting linkage disequilibrium from pooled DNA: A contingency table perspective
Pooling DNA samples of multiple individuals has been advocated as a method to reduce genotyping costs. Under such a scheme, only the allele counts at each locus, not the haplotype information, are observed. We develop a systematic way for handling such data by formulating the problem in terms of contingency tables, where pooled allele counts are expressed as the margins and the haplotype counts correspond to the unobserved cell counts. We show that the cell frequencies can be uniquely determined from the marginal frequencies under the usual Hardy–Weinberg equilibrium (HWE) assumption and that the maximum likelihood estimates of haplotype frequencies are consistent and asymptotically normal as the number of pools increases. The limiting covariance matrix is shown to be closely related to the extended hypergeometric distribution. Our results are used to derive Wald‐type tests for linkage disequilibrium (LD) coefficient using pooled data. It is discovered that pooling is not efficient in testing weak LD despite its efficiency in estimating haplotype frequencies. We also show by simulations that the proposed LD tests are robust to slight deviation from HWE and to minor genotype error. Applications to two real angiotensinogen gene data sets are also provided. Copyright © 2008 John Wiley & Sons, Ltd.
- 12 June 2008
- Published by Springer Nature in Science China Mathematics
- Vol. 51 (10) , 1843-1854
Random weighting method for Cox’s proportional hazards model
- 12 June 2008
- Published by Springer Nature in Science China Mathematics
- Vol. 51 (10) , 1843-1854
Random weighting method for Cox’s proportional hazards model